Ulrike Resch

Dr. Ulrike Resch

Vascular Biology and Thrombosis Research, Medical University of Vienna, Vienna, Wien, Austria
orcid
busy in the lab- because science

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2015 in Immunity
Verified
Journal Article
Closed access
AHAnetta Härtlova
Anetta Härtlova
SESaskia F. Erttmann
Saskia F. Erttmann
FRFaizal Am. Raffi
Faizal Am. Raffi
ASAnja M. Schmalz
Anja M. Schmalz
Ulrike ReschUlrike Resch
Ulrike Resch
NGNelson O. Gekara
Nelson O. Gekara

1 May 2018 in Trends in Microbiology
Verified
Journal Article
Closed access
JTJames A. Tsatsaronis
James A. Tsatsaronis
SFSandra Franch-Arroyo
Sandra Franch-Arroyo
Ulrike ReschUlrike Resch
Ulrike Resch
ECEmmanuelle Charpentier
Emmanuelle Charpentier

30 December 2016 in mBio
Verified
Journal Article
Open access
PDF file
Ulrike ReschUlrike Resch
Ulrike Resch
JTJames Anthony Tsatsaronis
James Anthony Tsatsaronis
ARAnaïs Le Rhun
Anaïs Le Rhun
GSGerald Stübiger
Gerald Stübiger
MRManfred Rohde
Manfred Rohde
ECEmmanuelle Charpentier
Emmanuelle Charpentier
Export of macromolecules via extracellular membrane-derived vesicles (MVs) plays an important role in the biology of Gram-negative bacteria. Gram-positive bacteria have also recently been reported to produce MVs; however, the composition and mechanisms governing vesiculogenesis in Gram-positive bacteria remain undefined. Here, we describe MV production in the Gram-positive human pathogen group A streptococcus (GAS), the etiological agent of necrotizing fasciitis and streptococcal toxic shock syndrome. M1 serotype GAS isolates in culture exhibit MV structures both on the cell wall surface and in the near vicinity of bacterial cells. A comprehensive analysis of MV proteins identified both virulence-associated protein substrates of the general secretory pathway in addition to “anchorless surface proteins.” Characteristic differences in the contents, distributions, and fatty acid compositions of specific lipids between MVs and GAS cell membrane were also observed. Furthermore, deep RNA sequencing of vesicular RNAs revealed that GAS MVs contained differentially abundant RNA species relative to bacterial cellular RNA. MV production by GAS strains varied in a manner dependent on an intact two-component system, CovRS, with MV production negatively regulated by the system. Modulation of MV production through CovRS was found to be independent of both GAS cysteine protease SpeB and capsule biosynthesis. Our data provide an explanation for GAS secretion of macromolecules, including RNAs, lipids, and proteins, and illustrate a regulatory mechanism coordinating this secretory response. IMPORTANCE Group A streptococcus (GAS) is a Gram-positive bacterial pathogen responsible for more than 500,000 deaths annually. Establishment of GAS infection is dependent on a suite of proteins exported via the general secretory pathway. Here, we show that GAS naturally produces extracellular vesicles with a unique lipid composition that are laden with proteins and RNAs. Interestingly, both virulence-associated proteins and RNA species were found to be differentially abundant in vesicles relative to the bacteria. Furthermore, we show that genetic disruption of the virulence-associated two-component regulator CovRS leads to an increase in vesicle production. This study comprehensively describes the protein, RNA, and lipid composition of GAS-secreted MVs and alludes to a regulatory system impacting this process.

2 January 2002 in Clinical Chemistry and Laboratory Medicine (CCLM)
Verified
Journal Article
Closed access
Ulrike ReschUlrike Resch
Ulrike Resch
GHGwen Helsel
Gwen Helsel
FTFranz Tatzber
Franz Tatzber
HSHelmut Sinzinger
Helmut Sinzinger
Our study was designed to test and compare the levels of enzymatic antioxidants (ARS), endogenous peroxides (POX), non-enzymatic antioxidants (Antiox-cap) and anti-oxidized low-density lipoprotein (LDL) antibody titers (oLAb) in hyperthyroid and hypothyroid patients. We measured POX, ARS, Antiox-cap and oLAb in the plasma from 68 patients (34 patients with hyperthyroidism, thyroid-stimulating hormone (TSH) 4.0) and 34 healthy euthyroid controls. POX were highest in hyperthyroid patients, but differences between hyperthyroid and hypothyroid patients and controls were not significant. ARS were significantly higher in patients compared to controls. Antiox-cap were significantly lower in patients compared to controls. oLAb were significantly higher in hypothyroid patients compared to controls and hyperthyroid patients. Our study shows that both hyperthyroidism and hypothyroidism are associated with enhanced oxidative stress involving enzymatic and non-enzymatic antioxidants. Higher POX in hyperthyroid patients might reflect the hypermetabolic state of these patients. oLAb, indicating progression of atherosclerosis, were highest in hypothyroid patients.

1 October 2009 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
YSYvonne M. Schichl
Yvonne M. Schichl
Ulrike ReschUlrike Resch
Ulrike Resch
RHRenate Hofer-Warbinek
Renate Hofer-Warbinek
Rainer de MartinRainer de Martin
Rainer de Martin
Tristetraprolin (TTP) is a prototypic family member of CCCH-type tandem zinc-finger domain proteins that regulate mRNA destabilization in eukaryotic cells. TTP binds to AU-rich elements (AREs) in the 3′-untranslated region of certain mRNAs, including tumor necrosis factor α, granulocyte macrophage colony-stimulating factor, and immediate early response 3, thereby facilitating their ARE-mediated decay. Expression of TTP is up-regulated by a variety of agents, including inflammatory mediators such as tumor necrosis factor α, a prominent activator of the nuclear factor κB (NF-κB) family of transcription factors. Accordingly, TTP is involved in the negative feedback regulation of NF-κB through promoting mRNA degradation. We describe here a novel, ARE-mediated decay-independent function of TTP on the termination of NF-κB response: TTP suppresses the transcriptional activity of NF-κB-dependent promoters independent of its mRNA-destabilizing property. In TTP knock-out mouse embryonic fibroblasts, lack of TTP leads to enhanced nuclear p65 levels, which is associated with the up-regulation of specific, ARE-less NF-κB target genes. We find that attenuation of NF-κB activity is at least in part due to an interference of TTP with the nuclear import of the p65 subunit of the transcription factor. This novel role of TTP may synergize with its mRNA-degrading function to contribute to the efficient regulation of proinflammatory gene expression.

20 December 2005 in British Journal of Clinical Pharmacology
Verified
Journal Article
Closed access
PDF file
Ulrike ReschUlrike Resch
Ulrike Resch
FTFranz Tatzber
Franz Tatzber
ABAlexandra Budinsky
Alexandra Budinsky
HSHelmut Sinzinger
Helmut Sinzinger